Although current research does not extensively cover the direct involvement of DDX41 in metabolic diseases such as obesity, diabetes, fatty liver diseases, or cardiovascular diseases, there are emerging lines of evidence suggesting its broader relevance. Here, DDX41 is linked to obesity due to melanocortin 4 receptor deficiency.